MedPath
NMPA Approval

Tolterodine L-Tartrate Sustained Release Capsules

H20181074

February 3, 2018

H20130324

Drug Information

酒石酸托特罗定缓释胶囊

胶囊剂

2mg

化学药品

February 3, 2018

February 2, 2023

Company Information

Applicant Company

Via Vittor Pisani 20, 20124 Milano, Italy

Manufacturing Company

1100 Enterprise Drive, Winchester, Kentucky, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酒石酸托特罗定缓释胶囊 - NMPA 批准文号 | MedPath